115 related articles for article (PubMed ID: 3479415)
1. Modification of the cysteamine side chain of thienamycin. III.
Sato M; Takemura M; Atarashi S; Higashi K; Nagahara T; Furukawa M; Ikeuchi T; Osada Y
J Antibiot (Tokyo); 1987 Sep; 40(9):1292-302. PubMed ID: 3479415
[TBL] [Abstract][Full Text] [Related]
2. Modification of the cysteamine side chain of thienamycin. II.
Sato M; Takemura M; Atarashi S; Higashi K; Fujiwara H; Nagahara T; Furukawa M; Ikeuchi T; Ozawa S; Nishizawa N
J Antibiot (Tokyo); 1987 Apr; 40(4):483-95. PubMed ID: 3583917
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro activity of 1 beta-methyl C-2 quaternary heterocyclic alkylthio carbapenems.
Kim CU; Luh BY; Misco PF; Hitchcock JM
J Med Chem; 1989 Mar; 32(3):601-4. PubMed ID: 2918506
[TBL] [Abstract][Full Text] [Related]
4. Thienamycin: development of imipenen-cilastatin.
Kahan FM; Kropp H; Sundelof JG; Birnbaum J
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
[TBL] [Abstract][Full Text] [Related]
5. Heteroaryliumthio substituted carbapenem derivatives: synthesis and in vitro activity of 1 beta-methyl-2-(dihydropyrrolotriazoliumthio)carbapenems.
Wildonger KJ; Ratcliffe RW
J Antibiot (Tokyo); 1993 Dec; 46(12):1866-82. PubMed ID: 8294246
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro activity of C-2 quaternary heterocyclic alkylthio carbapenems.
Kim CU; Misco PF; Luh BY; Hitchcock MJ
J Antibiot (Tokyo); 1987 Dec; 40(12):1707-15. PubMed ID: 3429337
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria.
Mitsuhashi S
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914
[TBL] [Abstract][Full Text] [Related]
8. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
Edwards JR
New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimicrobial activity of a new penem, sodium (5R,6S)-2-(2-fluoroethylthio)-6-[(1R)-1-hydroxyethyl]penem-3- carboxylate.
Kawamoto I; Endo R; Sugawara S
J Antibiot (Tokyo); 1986 Nov; 39(11):1551-6. PubMed ID: 3793624
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
11. Novel C-2 substituted carbapenem derivatives. Part II. Synthesis and structure-activity relationships of isoxazolin-2-yl, isoxazolidin-2-yl and 2-pyrazolin-2-yl carbapenems generated using 1,3-dipolar cycloaddition chemistry.
Burton G; Clarke GJ; Douglas JD; Eglington AJ; Frydrych CH; Hinks JD; Hird NW; Hunt E; Moss SF; Naylor A; Nicholson NH; Pearson MJ
J Antibiot (Tokyo); 1996 Dec; 49(12):1266-74. PubMed ID: 9031673
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity and chemical modifications of PS-5 at the C-3 side chain.
Sakamoto M; Yamamoto K; Isshiki K; Ishikura T; Fukagawa Y; Yoshioka T
J Antibiot (Tokyo); 1990 Oct; 43(10):1254-70. PubMed ID: 2258325
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of biapenem against recent gram-negative and gram-positive clinical isolates.
Bonfiglio G; Maccarone G; Mezzatesta ML; Privitera A; Carciotto V; Santagati M; Stefani S; Nicoletti G
Chemotherapy; 1997; 43(6):393-3. PubMed ID: 9395852
[TBL] [Abstract][Full Text] [Related]
14. A novel carbapenem antibiotic, SM-7338 structure-activity relationships.
Sunagawa M; Matsumura H; Inoue T; Fukasawa M; Kato M
J Antibiot (Tokyo); 1990 May; 43(5):519-32. PubMed ID: 2358404
[TBL] [Abstract][Full Text] [Related]
15. Review of the in vitro spectrum of activity of imipenem.
Jones RN
Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of imipenem against 1386 clinical isolates.
Belobraydic KA; Qadri SM
Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
[TBL] [Abstract][Full Text] [Related]
17. Meropenem: a new carbapenem antimicrobial.
Pryka RD; Haig GM
Ann Pharmacother; 1994 Sep; 28(9):1045-54. PubMed ID: 7803882
[TBL] [Abstract][Full Text] [Related]
18. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-antimicrobial activity relationships of quaternary ammonium derivatives of perhydropyrrolo-[3,4-c]pyridine.
Altomare C; Carotti A; Casini G; Cellamare S; Ferappi M; Vitali C
Arzneimittelforschung; 1992 Feb; 42(2):152-5. PubMed ID: 1610427
[TBL] [Abstract][Full Text] [Related]
20. New penem compounds with 5'-substituted pyrrolidinylthio group as a C-2 side chain; comparison of their biological properties with those of carbapenem compounds.
Sunagawa M; Matsumura H; Inoue T; Fukasawa M
J Antibiot (Tokyo); 1992 Apr; 45(4):500-4. PubMed ID: 1592682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
